Article metrics

Protocol
Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castration-resistant prostate carcinoma

 

Online download statistics by month:

Online download statistics by month: October 2020 to October 2021

AbstractFullPdf
Oct 202028027792
Nov 202010410250
Dec 2020807742
Jan 2021494625
Feb 2021474718
Mar 2021474517
Apr 2021262517
May 2021414124
Jun 202121216
Jul 2021383721
Aug 2021292817
Sep 2021363418
Oct 2021423933
Total840819380